Market Wire - Hersh & Hersh Announces Creation of Settlement Fund for Eli Lilly Zyprexa Lawsuits
San Francisco plaintiff rights law firm
Hersh & Hersh today announced the creation of a settlement fund for
personal injury lawsuits brought on behalf of people who were prescribed
the Eli Lilly drug Zyprexa and developed diabetes and other related
illnesses. Hersh & Hersh filed the first Zyprexa lawsuit in the United
States and has been pursuing cases for injured Zyprexa users for several
years. Nancy Hersh was one of four plaintiffs’ lawyers on the negotiating
committee in the Zyprexa nationwide litigation and was instrumental in
negotiating this $700,000,000.00 settlement. Hersh & Hersh represents
approximately 400 people across the country.
About Hersh & Hersh
Related Results
Antipsychotic-associated weight gain.(EVIDENCE-BASED PSYCHIATRIC MEDICINE)
FDA Issues Not-Approvable Letter for Lilly’s Zyprexa Long-Acting Inject…
Lilly and schering offer modest 4Q results. (News).(Brief Article)
Indianapolis-Based Eli Lilly Warns of Drug Tampering.
Testimony Regarding Eli Lilly Drug’s Patent-Worthiness Turns to Hormone Levels.
Hersh & Hersh (www.hershlaw.com) is a San Francisco-based law firm
dedicated to protecting the safety and rights of consumers. The law firm
represents clients both on an individual level and in class and
multi-district litigation, and has pursued and won a wide range of civil
suits, from product liability, medical malpractice and insurance bad faith
to sexual harassment and employee discrimination. For the past 33 years,
Hersh & Hersh has been committed to using the law to protect individuals by
making sure companies exercise due diligence in manufacturing their
products and operate in good faith in delivering their services.
Press Contact:
Lisa Byrne
415/221-5018
Email Contact
